Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

NCT00423514 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: filgrastim
DRUG: clofarabine
DRUG: melphalan
DRUG: mycophenolate mofetil
DRUG: tacrolimus
DRUG: thiotepa
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]